Science vs. Spin Podcast By Circle Of Insight Productions cover art

Science vs. Spin

Science vs. Spin

By: Circle Of Insight Productions
Listen for free

On Science vs. Spin, we break down viral research and show you what’s actually going on behind the curtain. Was the study done on humans—or rats? Was the sample size large enough to matter? Are we looking at real clinical outcomes… or just surrogate markers dressed up as breakthroughs?

Each episode teaches you how to think like a researcher, spot statistical sleight of hand, and separate meaningful evidence from media hype. Because once you understand how studies really work, you stop being misled—and start seeing the world more clearly.Copyright Circle Of Insight Productions
Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • The MIT AI Myth: Debunking the "95% Failure" Stat That Shook Markets
    May 3 2026
    In 2025, a viral study claiming that 95% of corporate AI pilots were failing sent the Nasdaq into a tailspin—but there was one problem: the math was 100% wrong. We join Rob Wiblin to dissect how a flawed report managed to hijack the global AI narrative and what the evidence actually says about the success of generative AI in the enterprise. Learn how to spot "data torture" and why the real story of AI integration is far more optimistic than the headlines suggest.
    Show more Show less
    6 mins
  • Vaping & Cancer: The 2026 Review – Real Risk or Overhyped Alarm?
    Apr 26 2026
    A major 2026 review in the journal Carcinogenesis claims nicotine vapes are “likely” to cause lung and oral cancers based on DNA damage, inflammation, and mouse tumors. Public-health experts on the other side call the paper misleading, arguing vaping remains far safer than smoking and a proven tool for quitting. We examine both arguments, expose the limitations of the studies on each side, and end with practical, no-nonsense advice for listeners.
    Show more Show less
    7 mins
  • Science vs Spin: Do Anti-Amyloid Drugs Actually Work for Alzheimer’s? The Cochrane vs Lancet Debate
    Apr 24 2026
    This episode examines the heated debate between the Cochrane Review and The Lancet on anti-amyloid drugs for Alzheimer’s. We break down the modest benefits, real risks, and methodological differences between older and newer treatments. A balanced, evidence-based analysis for patients, families, and clinicians seeking clarity on this controversial topic.
    Show more Show less
    4 mins
No reviews yet